Atipamezole

	WikiDoc Resources for Atipamezole
Articles
Most recent articles on Atipamezole Most cited articles on Atipamezole Review articles on Atipamezole Articles on Atipamezole in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Atipamezole Images of Atipamezole Photos of Atipamezole Podcasts & MP3s on Atipamezole Videos on Atipamezole
Evidence Based Medicine
Cochrane Collaboration on Atipamezole Bandolier on Atipamezole TRIP on Atipamezole
Clinical Trials
Ongoing Trials on Atipamezole at Clinical Trials.gov Trial results on Atipamezole Clinical Trials on Atipamezole at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Atipamezole NICE Guidance on Atipamezole NHS PRODIGY Guidance FDA on Atipamezole CDC on Atipamezole
Books
Books on Atipamezole
News
Atipamezole in the news Be alerted to news on Atipamezole News trends on Atipamezole
Commentary
Blogs on Atipamezole
Definitions
Definitions of Atipamezole
Patient Resources / Community
Patient resources on Atipamezole Discussion groups on Atipamezole Patient Handouts on Atipamezole Directions to Hospitals Treating Atipamezole Risk calculators and risk factors for Atipamezole
Healthcare Provider Resources
Symptoms of Atipamezole Causes & Risk Factors for Atipamezole Diagnostic studies for Atipamezole Treatment of Atipamezole
Continuing Medical Education (CME)
CME Programs on Atipamezole
International
Atipamezole en Espanol Atipamezole en Francais
Business
Atipamezole in the Marketplace Patents on Atipamezole
Experimental / Informatics
List of terms related to Atipamezole

Atipamezole
Clinical data
AHFS/Drugs.com	International Drug Names
ATCvet code	Template:Infobox drug/formatATCvet; Template:Infobox drug/formatATCvet;
Legal status
Legal status	Veterinary use only;
Identifiers
	IUPAC name 4-(2-Ethyl-1,3-dihydroinden-2-yl)-3H-imidazole;
CAS Number	104054-27-5 ;
PubChem CID	71310;
ChemSpider	64427 ;
UNII	03N9U5JAF6;
KEGG	D03002 ;
ChEMBL	ChEMBL353972 ;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C14H16N2
Molar mass	212.290 g/mol
3D model (JSmol)	Interactive image;
	SMILES n1cc(nc1)C3(Cc2c(cccc2)C3)CC;
	InChI InChI=1S/C14H16N2/c1-2-14(13-9-15-10-16-13)7-11-5-3-4-6-12(11)8-14/h3-6,9-10H,2,7-8H2,1H3,(H,15,16) ; Key:HSWPZIDYAHLZDD-UHFFFAOYSA-N ;
(what is this?) (verify)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Atipamezole (brand name Antisedan, Pfizer) is a synthetic α₂ adrenergic receptor antagonist, indicated for the reversal of the sedative and analgesic effects of dexmedetomidine and medetomidine in dogs.^[1] It has also been researched in humans as a potential anti-Parkinsonian drug.^[2]

References

↑ Pfizer Animal Health ANTISEDAN Product Overview
↑ Pertovaara A, Haapalinna A, Sirviö J, Virtanen R (2005). "Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist". CNS Drug Reviews. 11 (3): 273–88. doi:10.1111/j.1527-3458.2005.tb00047.x. PMID 16389294.

External links

ANTISEDAN product information page (Pfizer Animal Health)

[1] Pfizer Animal Health ANTISEDAN Product Overview

[pmid16389294-2] Pertovaara A, Haapalinna A, Sirviö J, Virtanen R (2005). "Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist". CNS Drug Reviews. 11 (3): 273–88. doi:10.1111/j.1527-3458.2005.tb00047.x. PMID 16389294.

[1]

[2]

Atipamezole

Overview

See also

References

External links

Navigation menu